cyclosporine has been researched along with Acute Anterior Wall Myocardial Infarction in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amaz, C; Bergerot, C; Besseyre des Horts, T; Bière, L; Croisille, P; Cung, TT; de Poli, F; Derumeaux, G; Garcia-Dorado, D; Gilard, M; Hovasse, T; Jossan, C; Mewton, N; Meyer, E; Ovize, M; Pezel, T; Prunier, F; Roubille, F; Schaaf, M; Thibault, H | 1 |
| Amaz, C; Claeys, MJ; Coussement, P; Dubois, P; Garcia-Dorado, D; Mewton, N; Ovize, M | 1 |
| Cai, H; Eghbali, M; Iorga, A; Li, J; Partow-Navid, R; Rahman, S; Sharma, S; Umar, S; Youn, JY | 1 |
| Ghaffari, S; Kazemi, B; Sepehrvand, N; Toluey, M | 1 |
3 trial(s) available for cyclosporine and Acute Anterior Wall Myocardial Infarction
| Article | Year |
|---|---|
Predictive value of early cardiac magnetic resonance imaging functional and geometric indexes for adverse left ventricular remodelling in patients with anterior ST-segment elevation myocardial infarction: A report from the CIRCUS study.
Topics: Aged; Anterior Wall Myocardial Infarction; Cyclosporine; Double-Blind Method; Early Diagnosis; Female; France; Heart Disease Risk Factors; Humans; Injections, Intravenous; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Percutaneous Coronary Intervention; Predictive Value of Tests; Risk Assessment; ST Elevation Myocardial Infarction; Time Factors; Treatment Outcome; Ventricular Function, Left; Ventricular Remodeling | 2020 |
Clinical effects of cyclosporine in acute anterior myocardial infarction complicated by heart failure: A subgroup analysis of the CIRCUS Trial.
Topics: Anterior Wall Myocardial Infarction; Cardiotonic Agents; Cyclosporine; Disease Progression; Double-Blind Method; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies | 2019 |
The effect of prethrombolytic cyclosporine-A injection on clinical outcome of acute anterior ST-elevation myocardial infarction.
Topics: Aged; Anterior Wall Myocardial Infarction; Arrhythmias, Cardiac; Chi-Square Distribution; Cyclosporine; Double-Blind Method; Drug Administration Schedule; Female; Fibrinolytic Agents; Heart Failure; Humans; Injections, Intravenous; Iran; Kaplan-Meier Estimate; Male; Middle Aged; Myocardium; Pilot Projects; Stroke Volume; Thrombolytic Therapy; Time Factors; Treatment Outcome; Ventricular Function, Left | 2013 |
1 other study(ies) available for cyclosporine and Acute Anterior Wall Myocardial Infarction
| Article | Year |
|---|---|
Intralipid, a clinically safe compound, protects the heart against ischemia-reperfusion injury more efficiently than cyclosporine-A.
Topics: Animals; Anterior Wall Myocardial Infarction; Blotting, Western; Calcium; Cardiotonic Agents; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Electron Spin Resonance Spectroscopy; Emulsions; Fat Emulsions, Intravenous; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Heart Function Tests; Immunosuppressive Agents; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mitochondria, Heart; Myocardial Reperfusion Injury; Necrosis; Oncogene Protein v-akt; Permeability; Phospholipids; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Soybean Oil | 2012 |